调节性T细胞在妇科疾病中的研究进展
摘要
和免疫耐受,又因其具有免疫抑制和免疫逃逸的功能,在维持免疫系统的平衡、预防自身免疫性疾病及调节免疫反
应起着关键性作用。Tregs作为免疫反应的主要效应细胞,其在疾病的诊断、治疗及预后起着至关重要的作用。因
此,在国内外Tregs的研究基础上,本文就近年来调节性T细胞在妇科疾病中的相关研究进展进行综述。
关键词
全文:
PDF参考
[1]Vallvé-Juanico, J.; Houshdaran, S.; Giudice, L. C.
The Endometrial Immune Environment of Women with
Endometriosis. Hum Reprod Update 2019, 25 (5), 565-592.
[2]Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh,
M.; Toda, M. Immunologic Self-Tolerance Maintained
by Activated T Cells Expressing IL-2 Receptor Alpha-Chains (CD25). Breakdown of a Single Mechanism of Self-Tolerance Causes Various Autoimmune Diseases. J Immunol
1995, 155 (3), 1151-1164.
[3]Dikiy, S.; Rudensky, A. Y. Principles of Regulatory
T Cell Function. Immunity 2023, 56 (2), 240-255.
[4]Cassar, E.; Kartikasari, A. E. R.; Plebanski, M.
Regulatory T Cells in Ovarian Carcinogenesis and Future
Therapeutic Opportunities. Cancers (Basel) 2022, 14 (22),
5488.
[5]郝梦启;姬佩雲;张雅丽. NLRC3、Foxp3在子
宫内膜异位症免疫失衡方面的研究进展. 承德医学院学
报 2023,40(3),245-249.
[6]Hou, J.; Wang, X.; Su, C.; Ma, W.; Zheng, X.; Ge, X.;
Duan, X. Reduced Frequencies of Foxp3+GARP+ Regulatory
T Cells in COPD Patients Are Associated with Multi-Organ
Loss of Tissue Phenotype. Respir Res 2022, 23, 176.
[7]Gao, M.; Liu, X.; Du, M.; Gu, H.; Xu, H.; Zhong,
X. Identification of Immune Cell Infiltration and Effective
Biomarkers of Polycystic Ovary Syndrome by Bioinformatics
Analysis. BMC Pregnancy Childbirth 2023, 23 (1), 377.
[8]MOULANA, M. Immunophenotypic Profile of
Leukocytes in Hyperandrogenemic Female Rat an Animal
Model of Polycystic Ovary Syndrome. Life Sci 2019, 220,
44-49.
[9]Krop, J.; Heidt, S.; Claas, F. H. J.; Eikmans, M.
Regulatory T Cells in Pregnancy: It Is Not All About FoxP3.
Front Immunol 2020, 11, 1182.
[10]Zenclussen, A. C.; Gerlof, K.; Zenclussen, M. L.;
Sollwedel, A.; Bertoja, A. Z.; Ritter, T.; Kotsch, K.; Leber,
J.; Volk, H.-D. Abnormal T-Cell Reactivity against Paternal
Antigens in Spontaneous Abortion. Am J Pathol 2005, 166 (3),
811-822.
[11]Green, S.; Politis, M.; Rallis, K. S.; Saenz de
Villaverde Cortabarria, A.; Efthymiou, A.; Mureanu, N.;
Dalrymple, K. V.; Scottà, C.; Lombardi, G.; Tribe, R.
M.; Nicolaides, K. H.; Shangaris, P. Regulatory T Cells in
Pregnancy Adverse Outcomes: A Systematic Review and
Meta-Analysis. Front Immunol 2021, 12, 737862.
[12]Wang, W.; Liu, J. R.; Zou, W. Immunotherapy in
Ovarian Cancer. Surg Oncol Clin N Am 2019, 28 (3), 447-464.
[13]Sato, S.; Matsushita, H.; Shintani, D.; Kobayashi,
Y.; Fujieda, N.; Yabuno, A.; Nishikawa, T.; Fujiwara, K.;
Kakimi, K.; Hasegawa, K. Association between Effector-Type
Regulatory T Cells and Immune Checkpoint Expression on
CD8+ T Cells in Malignant Ascites from Epithelial Ovarian
Cancer. BMC Cancer 2022, 22, 437.
[14]Ou, Y.; Cannon, M. J.; Nakagawa, M. Regulatory
T Cells in Gynecologic Cancer. MOJ Immunol 2018, 6 (2),
34-42.
[15]戴毅;郎景和;朱兰;冷金花. 子宫内膜异位症
诊治的现在和未来. 中国科学:生命科学 2021,51(8),
1017-1023.
[16]Higher Frequency of Circulating, but Not Tissue
Regulatory T Cells in Patients with Endometriosis. Journal of
Reproductive Immunology 2020, 139, 103119.
[17]李艳辉;耿育红;陈春艳;刘琳;高颖.
CD4~+CD25~+FOXP3~+调节性T淋巴细胞数量及功能
变化与子宫内膜异位症患者发病相关性研究. 现代妇产
科进展 2016,25(3),170-174.
Refbacks
- 当前没有refback。